Resistance Training and Neuroimaging (RTNI)
Cognitive Decline, Cerebrovascular Function

About this trial
This is an interventional basic science trial for Cognitive Decline
Eligibility Criteria
Inclusion Criteria:
- Community-dwelling and living independently (without need of assistance).
- Interest and availability for participation in a 12-week planned RT program at the CERC, including pre- and post- testing.
- Competency in English sufficient for assessment and training.
- Able to see and hear sufficiently to participate in RT.
- Not engaged in any structured exercise training outside of this intervention.
- Eligible to undergo MRI.
- Answer NO to all questions on the Physical Activity Readiness Questionnaire (PAR-Q) or receive medical clearance from a physician.
Exclusion Criteria:
- Possible Dementia (score less than or equal to 23 on MMSE).
- History of known neurological disease (e.g. Epilepsy, Multiple sclerosis, Parkinson disease, Alzheimer's disease), cerebral infarct (e.g. Stroke), or traumatic brain injury.
- History of known cardiovascular or metabolic disease or chronic illness which may compromise the patient's ability to safely perform the RT program (e.g. coronary artery disease, arrhythmia, asthma requiring an inhaler during exercise), or presently uncontrolled hypertension (SBP > 140 mmHg or DBP > 90 mmHg). Patient may be required to provide clearance from a physician at the study team's discretion.
- Type 1 or Type 2 Diabetes.
- Changes in chronic pharmacological treatment (e.g. Aspirin, Statins, or ACE inhibitors) or hormone therapy during the intervention period.
- Current treatment for congestive heart failure, angina, uncontrolled arrhythmia, DVT or other cardiovascular event.
- Myocardial infarction, coronary artery bypass grafting, angioplasty or other cardiac condition in the past year.
- Contraindications against MRI (e.g. metal implants, claustrophobia).
- Self-report regular heavy RT in the past 6 months (i.e. "strengthening exercises or lifting weights heavy enough that you could not perform more than 15 repetitions in one set").
- Musculoskeletal injuries interfering with the ability to perform RT or medical conditions for which exercise in contraindicated.
Sites / Locations
- Clinical Exercise Research Center
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control Period
Intervention Period
Participants will serve as their own controls. All 12-week control periods will take place before the RT intervention to ensure that results are not confounded by detraining effects or long-term cognitive benefits of RT. In addition, a control period equal in duration to the intervention allows direct within-subjects statistical comparisons, accounting for each participants' baseline and rate of aging - i.e. age-associated cognitive decline and arterial stiffening. Participants will not be monitored, but may be contacted for scheduling.
Participants will perform a periodized and progressive total-body RT program emphasizing development of lower and upper body strength. All 36 training sessions (3 days per week for 12 weeks) will be performed at the CERC, supervised by an exercise specialist. Participants will be encouraged to continue normal activities of daily living and eating routines outside the RT program of the present study. Because this is a proof-of concept study on normal aging, participants may be contacted for scheduling, but will not be monitored outside of training.